A number of animal and human studies suggest omega3-fatty acids are anti-inflammatory. As a result they may have a therapeutic role in inflammatory bowel disease(IBD). The aim of this review is to briefly assess the l...A number of animal and human studies suggest omega3-fatty acids are anti-inflammatory. As a result they may have a therapeutic role in inflammatory bowel disease(IBD). The aim of this review is to briefly assess the literature about the utility of poly-unsaturated fatty acids(PUFAs) in the management of IBD. Taken together, almost all studies suggest some beneficial effects of n-3 PUFAs in IBD but the mechanism remains controversial. In addition, clinical benefit seems to be largely confined to ulcerative colitis. However all studies have concluded that these compounds have no potential for a steroid/aminosalicylic acid sparing effect or to maintain remission. Now the question arises as to whether this treatment is of real value to IBD patients?Clearly they have some therapeutic potential but further work is needed.展开更多
文摘A number of animal and human studies suggest omega3-fatty acids are anti-inflammatory. As a result they may have a therapeutic role in inflammatory bowel disease(IBD). The aim of this review is to briefly assess the literature about the utility of poly-unsaturated fatty acids(PUFAs) in the management of IBD. Taken together, almost all studies suggest some beneficial effects of n-3 PUFAs in IBD but the mechanism remains controversial. In addition, clinical benefit seems to be largely confined to ulcerative colitis. However all studies have concluded that these compounds have no potential for a steroid/aminosalicylic acid sparing effect or to maintain remission. Now the question arises as to whether this treatment is of real value to IBD patients?Clearly they have some therapeutic potential but further work is needed.
